Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neurocrine starts tardive dyskinesia drug Phase II trial
The company is developing NBI-98854 to address the unmet medical needs of patients suffering from tardive dyskinesia (TD). The trial aims to evaluate once-daily NBI-98854 (12.5mg and 50mg)
The company is developing NBI-98854 to address the unmet medical needs of patients suffering from tardive dyskinesia (TD). The trial aims to evaluate once-daily NBI-98854 (12.5mg and 50mg)
Fluzone Intradermal, which uses microinjection system for intradermal delivery, is indicated for active immunization of adults 18 through 64 years of age against influenza. The injection features an
The cloud-based version of the SMRT Analysis software suite is designed to offer computing that scales to meet the data analysis needs for SMRT sequencing and supports a
The trial aims to evaluate the safety and tolerability of TrasGEX, a glycooptimized HER2 biobetter antibody. TrasGEX is developed using GlycoExpress, the company’s development and production platform based
Prior to joining PPD, Hill worked with IMS Health as the president of IMS Consulting Group. Before IMS, Hill served as the senior vice president for Acumen Sciences.
Curaxins are synthetic small molecules intended to simultaneously target major cell stress response pathways that are frequently deregulated in cancer. Incuron CEO Andrei Leonov said this prestigious Skolkovo
The combined company is expected to have a diversified revenue base from 12 products currently marketed in the US in the CNS and women’s health areas. Following the
The approval has been granted for 100mg/ml and 150mg/ml strengths. Enoxaparin Sodium Injection is the generic version of Lovenox of Sanofi-aventis and is indicated for the treatment of
Produced by Lincoln, Anapen is indicated as a treatment for anaphylactic shock. Under the five year agreement, Allergy has paid £600,000 to Lincoln. Allergy is selling Anapen in
NDV-3 is a prophylactic vaccine candidate which contains a recombinant Candida surface protein, Als3, and an adjuvant Alhydrogel. The study is designed to assess the efficacy of the